A Healthy Volunteer Receives an Intravenous Infusion of mAb114

A healthy volunteer receives an intravenous infusion of mAb114–an experimental treatment for Ebola virus disease–in a Phase 1 clinical trial held at the NIH Clinical Center in Bethesda, Md.
Image/NIAID